These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1402 related articles for article (PubMed ID: 9626048)

  • 1. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
    Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
    J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
    Samaniego F; Markham PD; Gallo RC; Ensoli B
    J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
    Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
    J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
    J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
    Chung CH; Chiang J; Jiang CM; Chen YY; Huang CY; Chen PG; Chen YJ
    Neoplasma; 2001; 48(3):192-9. PubMed ID: 11583288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells.
    Montaldo F; Maffé A; Morini M; Noonan D; Giordano S; Albini A; Prat M
    J Cell Physiol; 2000 Aug; 184(2):246-54. PubMed ID: 10867650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
    Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
    Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.